International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 678-684 , 1 March 2008

Clinical Outcomes of Patients Receiving Integrated PET/CT-Guided Radiotherapy for Head and Neck Carcinoma

  • Matthew R. Vernon, B.S.

      Affiliations

    • Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Mohit Maheshwari, M.D.

      Affiliations

    • Department of Radiology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Christopher J. Schultz, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Michelle A. Michel, M.D.

      Affiliations

    • Department of Radiology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Stuart J. Wong, M.D.

      Affiliations

    • Department of Neoplastic and Related Disorders, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Bruce H. Campbell, M.D.

      Affiliations

    • Department of Otolaryngology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Becky L. Massey, M.D.

      Affiliations

    • Department of Otolaryngology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • J. Frank Wilson, M.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Dian Wang, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
    • Corresponding Author InformationReprint requests to: Dian Wang, M.D., Ph.D., Department of Radiation Oncology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226. Tel: (414) 805-4496; Fax: (414) 805-4369

Received 12 August 2007 ,Revised 29 October 2007 ,Accepted 30 October 2007.

References 

  1. Adams S, Baum RP, Stuckensen T, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25:1255–1260
  2. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI, and endoscopy for staging head and neck squamous-cell carcinoma. J Nucl Med. 1995;36:1747–1757
  3. Kitagawa Y, Nishizawa S, Sano K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med. 2003;44:198–206
  4. Di Martino E, Nowak B, Hassan HA, et al. Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg. 2000;126:1457–1461
  5. Kluetz PG, Meltzer CC, Villemange VL, et al. Combined PET/CT imaging in oncology: Impact on patient management. Clin Positron Imaging. 2000;3:223–230
  6. Ciernik F, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys. 2003;57:853–863
  7. Kluetz P, Villemagne V, Meltzer C, et al. The Case for PET/CT. Experience at the University of Pittsburgh. Clin Positron Imaging. 2000;3:174
  8. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200–1209
  9. Roman CD, Martin WH, Delbeke D. Incremental value of fusion imaging with integrated PET-CT in oncology. Clin Nucl Med. 2005;30:470–477
  10. Heron DE, Andrade RS, Flickinger J, et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report. Int J Radiat Oncol Biol Phys. 2004;60:1419–1424
  11. Scarfone C, Lavely WC, Cmelak AJ, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med. 2004;45:543–552
  12. Nishioka T, Shiga T, Shirato H, et al. Image fusion between 18 FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys. 2002;53:1051–1057
  13. Koshy M, Paulino AC, Howell R, et al. F-18 PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck. 2005;27:494–502
  14. Wang D, Schultz CJ, Jursinic PA, et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2006;65:143–151
  15. Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Biol Phys. 2005;61:129–126
  16. Goshen E, Davidson T, Yahalom R, et al. PET/CT in the evaluation of patients with squamous cell cancer of the head and neck. Int J Maxillofac Surg. 2006;35:332–336
  17. Wong WL, Hussain K, Chevretton E, et al. Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images. Am J Surg. 1996;172:628–632
  18. Schoder H, Yeung HW, Gonen M, et al. Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65–72
  19. Zimny M, Wildberger JE, Cremerius U, et al. Combined image interpretation of computed tomography and hybrid PET in head and neck cancer. Nuklearmedizin. 2002;41:14–21
  20. Jeong HS, Baek CH, Son YI, et al. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck. 2007;29:203–210
  21. Ha PK, Hdeib A, Goldenberg D, et al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132:12–16
  22. Lee N, Puri DR, Blanco AI, Chao KS. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck. 2007;29:387–400
  23. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol. 2006;24:2618–2623
  24. Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck. 2005;27:478–487
  25. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  26. Chao KS, Low DA, Perez CA, Purdy JA. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience. Int J Cancer. 2000;90:92–103
  27. Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117–1126
  28. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312–321
  29. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49–60
  30. Yao M, Dornfield KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005;63:410–421
  31. Daly ME, Lieskovsky Y, Pawlicki T, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck. 2007;29:211–220
  32. Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002;24:127–135
  33. Kim SY, Roh JL, Kim MR, et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med. 2007;48:752–757
  34. Allal AS, Slosman DO, Kebdani T, et al. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004;59:1295–1300
  35. Schwartz DL, Rajendran J, Yueh B, et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg. 2004;130:1361–1367
  36. Greven KM, Williams DW, McGuirt WF, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001;23:942–946
  37. Intensity Modulated Radiation Therapy Collaborative Working Group . Intensity-modulated radiation therapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys. 2001;51:880–914
  38. Eisbruch A. Clinical aspects of IMRT for head-and-neck cancer. Med Dosim. 2002;27:99–104
  39. Puri DR, Chou W, Lee N. Intensity-modulated radiation therapy in head-and-neck cancers. Dosimetric advantages and update of clinical results. Am J Clin Oncol. 2005;28:415–423
  40. Chao KS. Protection of salivary gland function by intensity-modulated radiation therapy in patients with head and neck cancer. Semin Radiat Oncol. 2002;12(Suppl. 1):20–25
  41. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys. 2001;49:907–916
  42. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695–704
  43. Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Biol Phys. 2003;57:61–70
  44. Graff P, Lapeyre M, Desandes E, et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: Matched-pair comparison with conventional radiotherapy. Head Neck. 2007;67:1309–1317
  45. McMillan AS, Pow EH, Kwong DL, et al. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: Results of a prospective longitudinal study. Head Neck. 2006;28:712–722

 Conflict of interest: none.

PII: S0360-3016(07)04464-1

doi: 10.1016/j.ijrobp.2007.10.044

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 678-684 , 1 March 2008

Article Tools

* Image Usage & Resolution